India to New Zealand: Ondansetron Export Trade Route

The India to New Zealand Ondansetron corridor is one of India's established pharmaceutical export routes, with 61 shipments documented worth a combined $1.9M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 71% of all export value, reflecting the consolidated nature of India's ondansetron manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $31.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with ondansetron's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 19.6%, placing it at rank #19 among India's top ondansetron export destinations globally.

On the import side, key buyers of Indian ondansetron in New Zealand include NA, DR.REDDYS NEWZEALAND LIMITED , DR. REDDYS NEWZEALAND LIMITED and 10 others. NA is the single largest importer with 31 shipments valued at $1.3M USD.

India's ondansetron exports to New Zealand are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 36 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in New Zealand benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — IPCA LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD , DR.REDDY'S LABORATORIES LTD — together account for 92% of total trade value on this route. The average shipment value of $31.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as 300012466 ondansetron odt-drla 4 mg oral and harmless medicines periset odt 4mg tablets (ondansetron 4mg orally disintegrating tablets) (1x10s) (19000x1x10s pack), suggesting that buyers in New Zealand tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 31 shipments worth $1.3M USD — representing 68% of all ondansetron imports from India on this route. A total of 13 buyers are active on this corridor.